ABCC1 and head and neck squamous cell carcinoma: In line with previous reports pioneered by the Jentsch group, we argue that our in silico and in vitro data justify our decision to focus on VRAC rather than other transporters, such as MRP1, as the most relevant factor for cisplatin resistance in HNSCC [13,14,15,20].